The falsified products include Venetoclax Tablets (Batch No. 1274253), used in blood cancers; Nandrolone Decanoate Injection (Batch No. G401852), a hormonal therapy; Thrombophob ointment (Batch No. I403999), used for treating superficial blood clots; Amoxicillin-Clavulanate tablets under the brands Augmentin 625 Duo (Batch No. 824D269) and Clavam 625 (Batch No. 24441030), both widely prescribed antibiotics; Pantoprazole tablets PAN 40 (Batch No. 23440679), an anti-ulcer drug; and Telma H tablets (Batch Nos. 18230729 and 18210121), an antihypertensive combination of Telmisartan and Hydrochlorothiazide.
The aforementioned batches of vital medications, according to official reports, failed authenticity checks in July 2025 at CDSCO laboratories in Chandigarh and Kolkata during routine testing.
According to CDSCO, “The product is purported to be spurious; however, the same is subject to the outcome of the investigation.”
The matter came to light when the actual manufacturers, as per the label claim, confirmed that the impugned batches were never produced by them, thereby confirming the products as spurious.
In accordance with the Drug and Cosmetic Act, a drug shall be deemed to be spurious—
(a) if it is imported under a name which belongs to another drug; or
(b) if it is an imitation of, or a substitute for, another drug or resembles another drug in a manner likely to deceive or bears upon it or upon its label or container the name of another drug unless it is plainly and conspicuously marked so as to reveal its true character and its lack of identity with such other drug; or
(c) if the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist; or
(d) if it has been substituted wholly or in part by another drug or substance; or
(e) if it purports to be the product of a manufacturer of whom it is not truly a product
Medicines Flagged as Spurious
S. No. | Product Name | Batch No. | Mfg. Date | Exp. Date | Manufacturer Name | Manufactured By | Tested At (CDSCO Lab) | Test Month/Year | NSQ Remark | Firm Reply |
| Venetoclax Tablets 100 mg (Venclyxto Tablets) | 1274253 | N/A | Aug-2027 | N/A | N/A | RDTL, Chandigarh | Jul-2025 | The product is purported to be spurious, however, the same is subject to outcome of investigation | Actual manufacturer confirmed this batch was not manufactured by them; declared spurious drug |
| Nandrolone Decanoate Injection IP 50 mg/ml (Deca-Durabolin 50 Inj.) | G401852 | Jul-2024 | Jun-2028 | N/A | N/A | CDL, Kolkata | Jul-2025 | The product is purported to be spurious, however, the same is subject to outcome of investigation | Actual manufacturer confirmed this batch was not manufactured by them; declared spurious drug |
| Ointment of Heparin Sodium and Benzyl Nicotinate (Thrombophob) | I403999 | Aug-2024 | Jul-2027 | N/A | N/A | CDL, Kolkata | Jul-2025 | The product is purported to be spurious, however, the same is subject to outcome of investigation | Actual manufacturer confirmed this batch was not manufactured by them; declared spurious drug |
| Amoxycillin and Potassium Clavulanate Tablets IP (Augmentin 625 Duo) | 824D269 | Sep-2024 | N/A | N/A | N/A | CDL, Kolkata | Jul-2025 | The product is purported to be spurious, however, the same is subject to outcome of investigation | Actual manufacturer confirmed this batch was not manufactured by them; declared spurious drug |
| Pantoprazole Gastro-resistant Tablets IP (PAN 40) | 23440679 | Feb-2023 | Jul-2025 | N/A | N/A | CDL, Kolkata | Jul-2025 | The product is purported to be spurious, however, the same is subject to outcome of investigation | Actual manufacturer confirmed this batch was not manufactured by them; declared spurious drug |
| Amoxicillin and Potassium Clavulanate Tablets IP (Clavam 625) | 24441030 | Mar-2024 | Aug-2025 | N/A | N/A | CDL, Kolkata | Jul-2025 | The product is purported to be spurious, however, the same is subject to outcome of investigation | Actual manufacturer confirmed this batch was not manufactured by them; declared spurious drug |
| Telmisartan 40mg + Hydrochlorothiazide 12.5mg Tablets IP (Telma H) | 18230729 | Nov-2023 | Oct-2026 | N/A | N/A | CDL, Kolkata | Jul-2025 | The product is purported to be spurious, however, the same is subject to outcome of investigation | Actual manufacturer confirmed this batch was not manufactured by them; declared spurious drug |
| Telmisartan 40mg + Hydrochlorothiazide 12.5mg Tablets IP (Telma H) | 18210121 | Sep-2023 | Jul-2026 | N/A | N/A | CDL, Kolkata | Jul-2025 | The product is purported to be spurious, however, the same is subject to outcome of investigation | Actual manufacturer confirmed this batch was not manufactured by them; declared spurious drug |
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.